Breakthrough Drug TY1 Repairs DNA Damage After Heart Attacks

Scientists have developed a new drug called TY1 that helps repair DNA damage caused by disease. Early tests show it could speed up healing after heart attacks in animals. The drug works by boosting the body's natural ability to reverse tissue damage in unexpected ways.

TY1 is a synthetic version of an RNA molecule already found in the body. It belongs to a new class of drugs called exomers, designed to tackle tissue damage differently from existing treatments.

In laboratory studies, TY1 reduced scar formation after heart attacks. It does this by increasing immune cells that repair DNA damage and clear away harmful debris. The drug also enhances the activity of a gene called TREX1, which supports tissue recovery.

Beyond heart disease, TY1 shows promise in autoimmune conditions where the body attacks its own healthy tissue. Researchers now plan to move from animal testing to human clinical trials.

The next phase will determine whether TY1's benefits extend to human patients. If successful, it could offer a new way to treat heart damage and autoimmune disorders. The drug's ability to target DNA repair sets it apart from current therapies.